Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Total revenue $ 82,538 $ 0 $ 19,601
Operating expenses:      
Cost of revenue 0 0 160
Research and development 697,276 179,426 107,368
Selling, general and administrative 115,925 38,693 25,591
Total operating expenses 813,201 218,119 133,119
Loss from operations (730,663) (218,119) (113,518)
Other income (expense):      
Interest and other income 525 3,717 11,701
Change in fair value of derivative liabilities (20,116) 0 0
Transaction costs (4,516) 0 0
Other expense (5,184) (45) (31)
Loss before income taxes (759,954) (214,447) (101,848)
Income tax expense (benefit) (4,501) 2 (7,771)
Net loss $ (755,453) $ (214,449) $ (94,077)
Basic net loss per share (in usd per share) $ (1.22) $ (0.79) $ (0.37)
Diluted net loss per share (in usd per share) $ (1.22) $ (0.79) $ (0.37)
Basic weighted-average shares outstanding (in shares) 620,816,420 270,940,197 254,398,417
Diluted weighted-average shares outstanding (in shares) 620,816,420 270,940,197 254,398,417
Collaboration revenue      
Total revenue $ 82,538 $ 0 $ 0
Development services revenue      
Total revenue $ 0 $ 0 $ 19,601